Stay up to date on our latest NeuroBlu news and developments.

Publication

APA 2022: Holmusk Presents Two Posters Showing New Insights from Real-World Data at American Psychiatric Association

Real-world data reveals differences between diagnoses and phenotypes, and how polypharmacy affects functioning in patients.

May 24, 2022

VIEW

Publication

ISPOR 2022: Holmusk Presents Real-world Evidence on Comorbid Substance Use Disorder and Schizophrenia Severity

Holmusk offers new insights on the association between comorbid substance use disorders and illness severity in people with schizophrenia.

May 18, 2022

VIEW

Publication

ISPOR 2022: Holmusk Presents Study on Antidepressant Medications’ Impact on Difficult-to-Treat Depression

Holmusk offers new real-world evidence into patients with difficult-to-treat depression.

May 16, 2022

VIEW

Publication

Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu

Holmusk publishes paper in BMJ Open, centering on dataset available in NeuroBlu, and platform capabilities.

April 26, 2022

VIEW

Publication

Abstracts Present New Real-world Evidence at Annual Schizophrenia Conference

Holmusk provides new insights into schizophrenia that could support more individualized care pathways.

April 8, 2022

VIEW

New Release

Expanded real-world data, on-demand help, and other updates

Expanded dataset to enhance real-world impact. Boost efficiency with Help & Resources.

April 1, 2022

VIEW

New Release

Improved search experience and download visualizations

Filter search results and view data by categories. Download cohort visualizations to document your research.

February 4, 2022

VIEW

Publication

Study Results in New Information about ADHD Medications for Young Children

Holmusk presents results from the largest analysis to date evaluating treatment of ADHD for young children.

January 15, 2022

VIEW

Publication

Holmusk and JPS Announce New Publication on Factors Affecting Buprenorphine Treatment Attrition in Opioid Use Disorder

Study uses Real-World Data to describe important patterns in the treatment of opioid use disorder.

January 5, 2022

VIEW

New Release

Introducing NeuralRiskModels package and other updates

Build dynamic risk models. New functions in Code Studio to conduct research studies faster.

November 1, 2021

VIEW

Publication

Relationship Between Polypharmacy and Clinical Functioning in Patients With ADHD: A Retrospective Analysis of Real-World Data

Holmusk publishes abstract in American Academy of Child and Adolescent Psychiatry (AACAP) 68th Annual Meeting.

October 18, 2021

VIEW

New Release

Introducing guided research study tutorials, product and feature tours, and other updates

Enhanced experience with smoother onboarding journey, new CGI-S filter and new project organization tools.

October 12, 2021

VIEW

Publication

Insights from NeuroBlu’s Real-World Dataset: Buprenorphine Treatment Retention in Individuals with Opioid Use Disorder

Holmusk presents at American Society for Clinical Pathology (ASCP) 2021 Annual Meeting.

August 22, 2021

VIEW

Event

NeuroBlu Award: Call for Proposals

Holmusk invites start-ups and academics to submit proposals for projects using NeuroBlu.

August 21, 2021

VIEW

New Release

Introducing Python

Use Python to perform customized research studies on NeuroBlu.

July 1, 2021

VIEW

New Release

Introducing BluSuite, Project Notes and other updates

Conduct advanced analytics with ease, with enhanced visualizations and documentation of research notes.

March 31, 2021

VIEW
Back to top
Contact us